News
CDC: Children just as vulnerable to COVID as adults
October 14, 2021
There were 113 COVID-19 outbreaks in schools without mask requirements, in a study of 1,000 schools in Arizona.
News
No short-term death risk in elderly after COVID-19 vaccines
October 13, 2021
Early reports of deaths shortly after mRNA-based vaccination of very frail elderly patients in Norway prompted a nationwide safety study.
News
Omega-3s tame inflammation in elderly COVID-19 patients
October 13, 2021
Those who received an intravenous infusion had significant decreases from baseline to end of treatment in the neutrophil-to-lymphocyte ratio.
![1]()
News
Resident physician work-hour regulations associated with improved physician safety and health
October 13, 2021
Do consecutive work-hour restrictions for first-year resident physicians improve physician safety?
![1]()
News
Children and COVID-19: U.S. adds latest million cases in record time
October 12, 2021
Six million children make for a dubious milestone as new cases, ED visits, and vaccinations continue to drop.
News
AstraZeneca antibody cocktail study shows success treating COVID-19
October 12, 2021
The drug reduced the risk of severe COVID-19 or death by 50% in non-hospitalized patients who have had symptoms for seven days or less.
![1]()
News
Autopsy findings reveal venous thromboembolism in patients with COVID-19
October 12, 2021
What pathologic features contribute to the cause of death in COVID-19?
News
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
October 11, 2021
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
![1]()
News
New reports help nail down myocarditis risk with COVID-19 vaccine
October 11, 2021
Myocarditis linked to the two mRNA SARS-CoV-2 vaccines is rare, usually mild and self-limited, and a lot less likely than the usually more severe cases seen in COVID-19.
News
Merck seeks FDA authorization for antiviral COVID-19 pill
October 11, 2021
If the FDA grants authorization, the drug would be the first oral antiviral treatment for COVID-19.
